YouthConnect, Inc. in its spin-out from The Boys and Girls Clubs of Boston, Inc.
Apogee Therapeutics in its pending sale to AbbVie for approximately $10.9 billion
Catalyst Pharmaceuticals in its pending sale to Angelini Pharma for approximately $4.1 billion
Avidity Biosciences in its $12 billion sale to Novartis, and the related spin-off of its early-stage precision cardiology programs
Bain Capital Private Equity in its acquisition of Concert Golf Partners
Azul Systems on a majority strategic investment from Thoma Bravo
